Literature DB >> 29669244

Better Together: B7S1 Checkpoint Blockade Synergizes with anti-PD1.

Melissa A Meyer1, David G DeNardo2.   

Abstract

T cell checkpoint blockades can produce durable clinical responses, but only some patients and cancer types respond. In this issue of Immunity, Li et al. (2018) show B7S1-B7S1R signaling additionally regulates CD8+ T cell responses by working with the PD1-PDL1 checkpoint to block anti-tumor immunity.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2018        PMID： 29669244     DOI： 10.1016/j.immuni.2018.03.029

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  3 in total

1.  The combined expressions of B7H4 and ACOT4 in cancer-associated fibroblasts are related to poor prognosis in patients with gastric carcinoma.

Authors:  Qing Li; Yu'e Yang; Xin Jiang; Yufen Jin; Jingyi Wu; Yan Qin; Xiaowei Qi; Yang Cheng; Yong Mao; Dong Hua
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

2.  Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer.

Authors:  Emma Kurz; Carolina Alcantara Hirsch; Tanner Dalton; Sorin Alberto Shadaloey; Alireza Khodadadi-Jamayran; George Miller; Sumedha Pareek; Hajar Rajaei; Chirayu Mohindroo; Seyda Baydogan; An Ngo-Huang; Nathan Parker; Matthew H G Katz; Maria Petzel; Emily Vucic; Florencia McAllister; Keri Schadler; Rafael Winograd; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2022-06-02       Impact factor: 38.585

3.  B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.

Authors:  Maite Emaldi; Caroline E Nunes-Xavier
Journal:  Cells       Date:  2022-04-25       Impact factor: 7.666
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.